Daily news email for July 12, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Berthold Awards Marlene DeLuca Prices

Berthold Launches TriStar² Microplate Reader

Encap Announces $ 2 Million Capital Expenditure Programme

Encap Announces $2M Capital Expenditure Programme

Medicyte Coordinates EU-funded Collaboration on Biomimetic Bioartificial Liver

BioSpace
Blow for BioInvent as Vascular Treatment Fails

Walvax Biotech Gains Majority Control of Fengmao Biotech

Cancer: New Insights Into Taspase1 Function, Johannes Gutenberg University Study

Links Medical Receives Both FDA & EU Market Clearance for Advance Wound Care Products With Medical-Grade Manuka Honey

Gene Flaw Explains Why Drugs Failed to Treat MS, Oxford University Study

BioSpace - Breaking News
Orexigen Therapeutics, Inc. Announces the Light Study is Enrolling Faster than Originally Projected

OncoGenex Pharmaceuticals Inc. Announces Clinical Development Plans for Custirsen in Non-Small Cell Lung Cancer

Spinal Restoration, Inc. Completes Enrollment of the Phase III Study of the Biostat System

OncoSec Medical Inc. Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California, San Francisco (UCSF)

Oxford BioMedica PLC Announces Initiation of Phase II Collaborative Study for TroVax® in Colorectal Cancer

Biotech News - Business Wire
Research and Markets: Branching Random Walks in Nonhomogenous Environments

MedExpress Urgent Care Selects athenahealth to Achieve Operational Productivity

deCODE Genetics Discovers Mutation Conferring Protection Against Alzheimer's Disease and Cognitive Decline in Elderly

Ag Energy Coalition Urges House Agriculture Committee to Support Job Creation Through Farm Bill Energy Programs

Research and Markets: Stem Cell Research in India 2012

Biotech News - PR Newswire
Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012

Watson's Generic ARTHROTEC(R) Receives FDA Approval

Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control

Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration

Happtique Releases Draft App Certification Program Standards For Public Comment

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Obama Signs User Fee Bill

Cells From Parkinson's Patients Show Unique Drug Responses

GSK to Pay $3 Billion to Settle Civil and Criminal Charges with U.S. and States

Pfizer Grants Russia's SatRx Rights to Diabetes Compound

BMS to Acquire Amylin for $5.3 Billion Plus Debt

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Research and Markets: Global Human Papillomavirus Testing Market 2011-2015

Customer Survey Shows High Satisfaction Rate with ReVision Optics Near Vision Inlay for Presbyopia

Cross Country Healthcare Enters into New Credit Facility

Research and Markets: Mitral Regurgitation Global Clinical Trials Review, H1, 2012

First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro's Chronic Pain Treatment

Clinical Trials - PR Newswire
FHI 360: Final Results Of FEM-PrEP HIV-Prevention Study Indicate Great Attention To Adherence Will Be Required In PrEP Programs

World's First Intensive Study of Postpartum Women with von Willebrand Disease Shows Potential Risk of Delayed Hemorrhage, Despite Treatment

Retina Institute of Hawaii Participating in Allergan Investigational Drug Study for Wet Age-Related Macular Degeneration

New Grants for Innovative Alzheimer's Disease Research Announced by AHAF

1st SynCardia Total Artificial Heart Implant Performed in New England

CNN Top Stories
Hear Bieber's rant on 911 call

Stink bugs threaten wineries

Decision on abortion clinic delayed

Voters: Can we move on, please

House tries again to repeal Obamacare

Contract Pharma
Jubilant Implements Emerson Automation Technologies

DKSH, GSK in Distribution Pact

Rottendorf in Tumor Therapy Research Program

Tris Pharma Expands Manufacturing Capacity

Quintiles Introduces Allume Launch Process

FDA Drugs- What's New
FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)

FDA Drug Safety Communication: Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA News - Business Wire
BioControl Medical Gets Nod to Begin Second Phase of the INOVATE-HF Study of Its CardioFit® System

Links Medical Receives Both FDA & EU Market Clearance for Advance Wound Care Products with Medical-Grade Manuka Honey

Vitrolife AB (publ): Application for Market Approval of STEEN Solution in the USA Has Been Submitted to the FDA

El revolucionario sistema ARTAS de Restoration Robotics obtiene marca CE para el tratamiento de la pérdida capilar

ABMC Announces Signing of Consent Decree Related to Its OralStat® Product

FDA Press Releases
Wisconsin livestock dealer enters into consent decree involving drug residues in cows

FDA approves first over-the-counter home-use rapid HIV test

FDA introduces new safety measures for extended-release and long-acting opioid medications

FDA approves genetic test to help some colon cancer patients, physicians considering Erbitux therapy

FDA approves first DNA test to help manage CMV infection in organ transplant patients

FDA Vaccines, Blood and Biologics - What's New
Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FierceBiotech
Biotech fundraising sours in a bleak first half

BioInvent plunges (again) as another trial ends in disaster

Analysts give Arena's Belviq thumbs down in Japan

Edmond de Rothschild scores $152M for its fourth biotech fund

In latest R&D setback, Lilly's schizophrenia drug flunks a PhIII

FierceBiotech IT
Intel and NextBio seek Big Data upgrades in genomics

Eli Lilly aims to up social media game

23andMe bets on patient-driven research with CureTogether buyout

Supercomputer, sequencing uncover clue to doc's unlikely cancer

Mount Sinai Medical Center, Cloudera embrace Big Data in genomics

FierceBiotech Research
Alnylam generates preclinical buzz with RNAi hemophilia drug

Report: U.K. animal research involving monkeys drops drastically

Mouse model connects specific gene to liver cancer advance

Key molecule spotted as possible lung cancer weapon

Acadia's Parkinson's drug shows promise in treating Alzheimer's psychosis

FiercePharma
Bristol-Myers plots $165M plant expansion in Puerto Rico

Shire one of many injured in patent free-for-all

New cancer drugs debut faster in U.S., but they cost more

Glaxo's new HIV combo trounces Gilead's Atripla

Lilly aims to harmonize its social-media voices

FiercePharma Manufacturing
Drug manufacturing suffers as Pakistan scandal heats up

Hospira shortage can't be blamed for woman's blindness

Lilly CEO says for some products Ireland offers more than Asia

EU Parliament deep-sixes counterfeiting law, drugs and all

Spanish API maker has problems with tests, pests and water

FierceVaccines
PsiOxus lands $34M for cancer vax research

Norway's Bionor snags $1.7 million for HIV vaccine research

Rotund rodents shed pounds with new vaccine

PsiOxus lands $34 million for cancer vax research

Immunotherapy bats out Type 1 diabetes in mice

Health News - BizJournals.com
House votes to repeal Obamacare

House passes vote to repeal health reform

Lifelong Vision Foundation receives $1 million grant from Bausch & Lomb

Mako Surgical shares hit new 52-week low

Verastem buys Pfizer cancer drug candidate

Health News - CNBC
Merck says osteoporosis drug worked in study

Judge extends halt to new Mississippi abortion law

Arena files for approval of Belviq in Switzerland

Smartphones may aid eye diagnoses in emergency room

OxyContin abuse down with time-release formula

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
RCT Taps Isogenica for Screening Engineered Antibody CH2 Domains

CureBeta Snags $8M Up Front for Beta-Cell Regeneration Candidates

Breast Cancer Therapy Disappoints

Eisai and Galenea Team Up to Fight Neurodegenerative Diseases

Janssen Pays CureBeta $8M Up Front for Beta-Cell Regeneration Candidates

Marketwire - Pharma and Biotech
Thallion Announces 2012 Second Quarter Results

Thallion annonce ses rltats pour le deuxi trimestre 2012

Digital Infuzion Awarded 10-Year National Institutes of Health CIO-SP3 Contract Vehicle With $20B Ceiling

Bio-Rad to Report Second-Quarter 2012 Financial Results Tuesday, August 7, 2012

The Medicines Company to Announce Second Quarter 2012 Financial Results on Wednesday, July 25, 2012

MassBio News
Four Entrepreneurs Begin MassCONNECT Mentoring

BioPharm America 2012 program to feature first SciBX: Science-Business eXchange Innovation in BioPharma Summit

The Massachusetts Life Sciences Center 2012-13 Accelerator Loan Program

MassBio Commends Governor, Lawmakers for Ensuring Patient Access, Physician Education

Breaking: Supreme Court Upholds Affordable Care Act

Medical Pharma - PR Newswire
XX. FIGO-Weltkongress: Lohnenderwissenschaftlicher Austausch für die Gesundheit von Frauen weltweit

The Summertime Liposuction Spike

Dr. Matthew Samra of Fair Lawn, NJ is Honored as a Compassionate Doctor

BD Announces Agreement to Acquire Safety Syringes, Inc.

XX Congresso Mundial FIGO: um intercâmbio científico recompensador em saúde mundial da mulher

National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

Nature Biotechnology
Incorporating biomarkers into clinical trial designs: points to consider

TAL effector RVD specificities and efficiencies

Gene therapy matures in the clinic

From academic solos to industrial symphonies

Reading cancer's blueprint

New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment

New York Times- Pharmaceuticals
Some Doctors Cash In by Being Their Own Pharmacist

Some Physicians Making Millions Selling Drugs

F.D.A. Rejects Mandatory Training in Painkillers for Doctors

F.D.A. Expedites Review of New Uses for Xarelto, an Anticlotting Drug

Drug Firm Guilty In Criminal Case

OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India

Pharma News - Business Wire
Allscripts e Quintiles formam parceria para desenvolver soluções de software para pesquisa clínica e de pós-aprovação

Update on Phase III Trial for Odanacatib, Merck's Investigational Cat-K Inhibitor for Osteoporosis

Research and Markets: U.S. Market Report for Diabetes Monitoring, Treatment and Drug Delivery - Expected to exceed $17.87 billion by 2018

Verastem Acquires Clinical-Stage FAK Inhibitor from Pfizer

Research and Markets: United States Market for Ankylosing Spondylitis Pharmacotherapy

Pharma News - PharmiWeb
Life Science Professionals: Annual Career Fair Announced

Keris Myrick of Los Angeles (Pasadena), Profiled in NY Times, Elected NAMI National Board President; Ralph Nelson of Visalia is Secretary

Prevent Retained Foreign Objects during Robotic Surgery, Says ECRI Institute PSO

Mastech Holdings, Inc. to Discuss Second Quarter 2012 Financial Results on July 25, 2012

Paramount Recruitment on Course to Meet 2012 Expansion Plan

Pharma News - PR Newswire
Pinnaclife And Hy-Vee Continue To Promote Health And Nutrition

New Federal Legislation Can Help Combat Teen Cough Medicine Abuse

Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women

Life Extension Foundation® Sponsors Magnesium Sulfate Study at University of Miami

New Video, Website Help Health Plan Sponsors, Patients and Policy Makers Maximize Prescription Drug Benefits, Reduce Wasteful Spending

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

PRWeb - Biotechnology
NSF-DBA, a Global Pharmaceutical and Medical Device Organization,...

Alpha Source, Inc. Awarded Five-Year GSA IT Schedule 70 Contract

Bayer CropScience acquires US-based biological company AgraQuest for...

SeraCare and Dr. James Westgard Bring a Focus on Analytical Quality...

Yulex Corp and Cooper Tire Receive $6.9 Million USDA Grant

PRWeb - Pharmaceuticals
Metal Hip Implant Alert: Stryker Hip Recall Of Rejuvenate And ABG II...

Winners Announced for the Myelofibrosis Challenge

EMR Consulting and Healthcare IT Resource EMRApproved Selects New COO

EtQ Self-Certifies under U.S.-EU Safe Harbor Framework

RxTran and Health Business Systems Partner to Provide Pharmacy...

Scientific American
'Improved' Cookstoves May Do Little to Reduce Harmful Indoor Emissions

New Moon for Pluto: Hubble Telescope Spots a 5th Plutonian Satellite

How the U.S. Accidentally Nuked Its Own Communications Satellite

Male Dragonflies Color Shift via Simple Chemical Reaction

Florid Findings: Male Dragonflies Color Shift via Simple Chemical Reaction

Sports - ESPN Basketball
Report: PG Turner to leave SMU, pursue pro job

Michigan St.-KU, Duke-UK lead '12-13 openers

Enlarged heart cited in former Cardinal's death

Former UCLA basketball player Heitz dies at 65

UCLA's Smith shapes up to put 2011 behind him

Sports News - ESPN
NCAA grants QB Sims waiver, will be eligible

Paterno defends Penn St. in pre-death letter

NCAA: Penn St. will have to answer to Emmert

FSU's Reid arrested on pot possession charge

Sources: Penn State trustees bracing for report

Xconomy Life Sciences
In Search of Meaningful GAIN in Renewal of Prescription Drug Act

Protagonist Criss-Crosses Pacific, in Search of New Peptide Drugs

NuoDB, Dailybreak, Vsnap & (Much, Much) More from the Boston Deals Roundup

Energy Technology Ventures Invests in San Diego's On-Ramp Wireless

Oakland University Incubator Focuses on Cleantech, Outreach

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)